Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients?

Despite the increasing number of stud- ies and evidence that functional capacity is associated with all-cause and cardiac mortality in patients with heart failure and coronary

Results: Compared with the controls; the mitral annular peak systolic flow velocity (Sm) value was significantly lower, while isovolumic contrac- tion time (IVCT), isovolumic

Fatih Çelmeli Department of Pediatrics, Division of Pediatric Allergy-Immunology, Antalya Training and Research Hospital, Antalya, Turkey Phone: +90 242 249 44 00

They reported a statistically significant decrease in basal FVC, FEV1 and FEF25- 75 values in patients (in the 60-85 age group) with spinal anaesthesia above the thoracic 6 th (T6)

Considering these literature data we hypothesized that losartan may favorably affect pulmonary vascular remodeling and might be non-inferior to nifedipine in the treatment of

pulmonary function and define the alterations in bronchial nitric oxide (NO) release in correlation with the vascu- lar endothelial NO release in patients with normal

The post-hoc analysis indicated that this difference was associated with the significantly higher mean walkwork exhibited by the obese in comparison to that of the

Introduction: This study aimed to determine the relationship of 6 minute walking test (6MWT) and cardiopulmonary exercise test (CPET) with each other and with the measures of